BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37324755)

  • 21. Long-term longevity and clinical outcomes of Linox S/SD implantable cardioverter-defibrillator leads: a single-center experience.
    Alasti M; Machado C; Mirzaee S; Healy S; Bittinger L; Adam D; Kotschet E; Krafchek J; Alison J
    J Interv Card Electrophysiol; 2021 Jun; 61(1):115-121. PubMed ID: 32488749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on small-diameter implantable cardioverter-defibrillator leads performance.
    van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee.
    Bennett MT; Ha AC; Exner DV; Tung SK; Parkash R; Connors S; Coutu B; Crystal E; Champagne J; Philippon F; Yee R; Stephenson EA; Nery PB; Essebag V; Sanatani S; Redfearn D; Krahn AD; Healey JS
    Heart Rhythm; 2013 Oct; 10(10):1478-81. PubMed ID: 23973950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term performance and lead failure analysis of the Durata defibrillation lead compared to its previous model, the recalled Riata defibrillation lead.
    Kleemann T; Nonnenmacher F; Strauss M; Kouraki K; Werner N; Fendt A; Zahn R
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2012-2019. PubMed ID: 31332876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee.
    Krahn AD; Champagne J; Healey JS; Cameron D; Simpson CS; Thibault B; Mangat I; Tung S; Sterns L; Birnie DH; Exner DV; Parkash R; Sivakumaran S; Davies T; Coutu B; Crystal E; Wolfe K; Verma A; Stephenson EA; Sanatani S; Gow R; Connors S; Paredes FA; Essebag V;
    Heart Rhythm; 2008 May; 5(5):639-42. PubMed ID: 18452862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First time description of early lead failure of the Linox Smart lead compared to other contemporary high-voltage leads.
    Weberndörfer V; Nyffenegger T; Russi I; Brinkert M; Berte B; Toggweiler S; Kobza R
    J Interv Card Electrophysiol; 2018 Jul; 52(2):173-177. PubMed ID: 29713860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulation Failure of the Linox Defibrillator Lead: A Case Report and Retrospective Review of a Single Center Experience.
    Howe AJ; McKeag NA; Wilson CM; Ashfield KP; Roberts MJ
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):686-9. PubMed ID: 25711237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter-defibrillator lead failure in children and young adults: a matter of lead diameter or lead design?
    Janson CM; Patel AR; Bonney WJ; Smoots K; Shah MJ
    J Am Coll Cardiol; 2014 Jan; 63(2):133-40. PubMed ID: 24140671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
    Ellis CR; Rottman JN
    Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal follow-up of implantable cardioverter defibrillator leads.
    Liu J; Brumberg G; Rattan R; Patel D; Adelstein E; Jain S; Saba S
    Am J Cardiol; 2014 Jan; 113(1):103-6. PubMed ID: 24176060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome of implantable cardioverter defibrillators with recalled and non-recalled leads in Japanese patients. Increased failure rate of the Sprint Fidelis lead.
    Yanagisawa S; Inden Y; Shimano M; Yoshida N; Ichiyanagi H; Fujita M; Ohguchi S; Ishikawa S; Kato H; Okumura S; Miyoshi A; Nagao T; Yamamoto T; Hirai M; Murohara T
    Circ J; 2014; 78(2):353-9. PubMed ID: 24270680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience.
    Richardson TD; Kolek MJ; Goyal SK; Shoemaker MB; Lewis AA; Rottman JN; Whalen SP; Ellis CR
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):36-42. PubMed ID: 24028661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study.
    Atallah J; Erickson CC; Cecchin F; Dubin AM; Law IH; Cohen MI; Lapage MJ; Cannon BC; Chun TU; Freedenberg V; Gierdalski M; Berul CI;
    Circulation; 2013 Jun; 127(24):2393-402. PubMed ID: 23694966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads.
    Ellenbogen KA; Gunderson BD; Stromberg KD; Swerdlow CD
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1169-77. PubMed ID: 24099976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience.
    Sung RK; Massie BM; Varosy PD; Moore H; Rumsfeld J; Lee BK; Keung E
    Heart Rhythm; 2012 Dec; 9(12):1954-61. PubMed ID: 22871583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Class I recall of defibrillator leads: a comparison of the Sprint Fidelis and Riata families.
    Liu J; Brumberg G; Rattan R; Jain S; Saba S
    Heart Rhythm; 2012 Aug; 9(8):1251-5. PubMed ID: 22484652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
    J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator.
    Danik SB; Mansour M; Singh J; Reddy VY; Ellinor PT; Milan D; Heist EK; d'Avila A; Ruskin JN; Mela T
    Heart Rhythm; 2007 Apr; 4(4):439-42. PubMed ID: 17399630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of the Linox
    Marai I; Milman A; Diamante R; Gurevitz O; Barlev D; Lipchenka I; Nof E; Glikson M; Beinart R
    Indian Pacing Electrophysiol J; 2020; 20(4):137-140. PubMed ID: 31862483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of the Durata implantable cardioverter defibrillator lead: results of an independent multicenter study.
    Rordorf R; Taravelli E; Forleo GB; Giannola G; Calzolari V; Tadeo G; Rossi S; Vicentini A; Curnis A; Serra P; Santamaria M; Calò L
    J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):676-681. PubMed ID: 31343450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.